• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Introduction and enzootic of A/H5N1 in Egypt: Virus evolution, pathogenicity and vaccine efficacy ten years on

tetano

Editor, Senior Moderator
Infect Genet Evol. 2016 Feb 22. pii: S1567-1348(16)30054-5. doi: 10.1016/j.meegid.2016.02.023. [Epub ahead of print]
[h=1]Introduction and enzootic of A/H5N1 in Egypt: Virus evolution, pathogenicity and vaccine efficacy ten years on.[/h] Abdelwhab EM[SUP]1[/SUP], Hassan MK[SUP]2[/SUP], Abdel-Moneim AS[SUP]3[/SUP], Naguib MM[SUP]1[/SUP], Mostafa A[SUP]4[/SUP], Hussein IT[SUP]5[/SUP], Arafa A[SUP]2[/SUP], Erfan AM[SUP]2[/SUP], Kilany WH[SUP]2[/SUP], Agour MG[SUP]6[/SUP], El-Kanawati Z[SUP]2[/SUP], Hussein HA[SUP]7[/SUP], Selim AA[SUP]2[/SUP], Kholousy S[SUP]2[/SUP], El-Naggar H[SUP]8[/SUP], El-Zoghby EF[SUP]2[/SUP], Samy AS[SUP]2[/SUP], Iqbal M[SUP]9[/SUP], Eid A[SUP]10[/SUP], Ibraheem EM[SUP]11[/SUP], Pleschka S[SUP]12[/SUP], Veits J[SUP]13[/SUP], Nasef SA[SUP]2[/SUP], Beer M[SUP]13[/SUP], Mettenleiter TC[SUP]13[/SUP], Grund C[SUP]13[/SUP], Ali MM[SUP]14[/SUP], Harder TC[SUP]13[/SUP], Hafez HM[SUP]15[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] It is almost a decade since the highly pathogenic H5N1 avian influenza virus (A/H5N1) of clade 2.2.1 was introduced to Egypt in 2005, most likely, via wild birds; marking the longest endemic status of influenza viruses in poultry outside Asia. The endemic A/H5N1 in Egypt still compromises the poultry industry, poses serious hazards to public health and threatens to become potentially pandemic. The control strategies adopted for A/H5N1 in Egyptian poultry using diverse vaccines in commercialized poultry neither eliminated the virus nor did they decrease its evolutionary rate. Several virus clades have evolved, a few of them disappeared and others prevailed. Disparate evolutionary traits in both birds and humans were manifested by accumulation of clade-specific mutations across viral genomes driven by a variety of selection pressures. Viruses in vaccinated poultry populations displayed higher mutation rates at the immunogenic epitopes, promoting viral escape and reducing vaccine efficiency. On the other hand, viruses isolated from humans displayed changes in the receptor binding domain, which increased the viral affinity to bind to human-type glycan receptors. Moreover, viral pathogenicity exhibited several patterns in different hosts. This review aims to provide an overview of the viral evolution, pathogenicity and vaccine efficacy of A/H5N1 in Egypt during the last ten years.
Copyright ? 2015. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] Egypt; H5N1; clade 2.2.1; genetic evolution; highly pathogenic avian influenza virus; pandemic threat

PMID: 26917362 [PubMed - as supplied by publisher]
 
Back
Top Bottom